Outcomes after surgery for spinal cord compression among men with metastatic prostate cancer

Spinal cord compression is a relatively common consequence of advanced, metastatic prostate cancer. Treatment has historically involved reconstructive surgery to relieve the compression and stabilize the spine.

PSA monitoring after prostate cancer surgery: how long is long enough?

A paper currently “in press” in the Journal of Urology suggests that annual PSA testing “may be safely discontinued after 10 years for men with a prostatectomy Gleason score 6 or less and/or limited life expectancy.”

What’s hot at the AUA annual meeting (Monday)?

With many hundreds of prostate cancer-specific posters and oral presentations each day at the meeting, even trying to pick the sessions one wants to cover can be a challenge, but some general trends are becoming evident.

What’s hot at the AUA annual meeting (Saturday)?

So the highlight of the meeting today has been a series of lectures given at the meeting of the Society for Urologic Oncology that were (to a large extent) focused on issues related to health outcomes and prostate cancer.

Can MVP help us to understand the genetics of prostate cancer?

According to an announcement from the Veterans Administration (VA), it intends to roll out a new program called the Million Veterans Program or MVP which will allow pre-approved research teams to access (de-identified) genetic, military exposure, health, and lifestyle information on U.S. veterans together through one single database.

The long-term results of RTOG 98-05 — an innovative brachytherapy trial

The recently published long-term results of RTOG 98-05 illustrate at least one way in which we can start to get better insight into the effectiveness and safety of new forms of treatment for localized prostate cancer as compared to older forms of treatment — without having to conduct complex and socially difficult randomized clinical trials.

Long-term QOL outcomes 4 years after PBRT

In a poster today at the Genitourinary Cancers Symposium, data was presented on 4-year follow-up of quality of life (QOL) among men treated with conformal proton beam radiation therapy (PBRT).

A new review of recent clinical outcomes after HIFU

High-intensity focused ultrasound (HIFU) continues to gain advocates as a minimally invasive form of treatment for patients with localized and locally advanced prostate cancer, as well as for patients requiring salvage therapy after first-line radiation and after radical prostatectomy.

New data on the 5-year complications of radical prostatectomy

The complex and common series of significant short- and long-term complications of radical prostatectomy (RP) — whether conducted with or without the assistance of a robot — are often not well understood by patients when they elect this form of treatment for localized prostate cancer.

Age and PSA level at initial testing may significantly impact prostate cancer-specific mortality

In early 2009 the European Randomized Study of Screening for Prostate Cancer (ESRPC) reported a reduction of 20 percent in prostate cancer-specific mortality in a screened cohort of men aged between 55 and 74 years of age — as opposed to an unscreened cohort with the same age constraints.

Online disease management services for the prostate cancer patient

As online technology has gradually improved we are starting to see the development of online health information management and outcome services that are designed for use by cancer patients in general and prostate cancer patients specifically.

10-year follow-up data on cryotherapy for prostate cancer

In a newly published report, a team of clinicians from Columbia University Medical Center has provided data on the 10-year follow-up of a small group of patients treated with salvage or primary cryotherapy for prostate cancer.

Comparative data on first-line radiation therapy — and the lack thereof

The Agency for Healthcare Research and Quality (AHRQ) has released a draft version of a detailed techology assessment report entitled, “Comparative evaluation of radiation treatments for clinically localized prostate cancer: an update.”

Outcomes-related data on prostate cancer patients followed for up to 43 years

Two papers to be presented by Lewinshtein and Porter at the Genitourinary Cancers Symposium (starting tomorrow in San Francisco) offer some interesting insights on patients initially treated as long ago as the mid-1950s.

Prostate cancer news reports: Thursday, February 18, 2010

Today’s news reports include commentary on studies dealing with: Whether RALP outcomes are really comparable to those from RRP Surgical expertise, surgical caseload, and pelvic lymphadenectomy in treatment of intermediate- and high-risk prostate cancer Sexual function after first-line treatment with SBRT (CyberKnife) Distinguishing true biochemical recurrence from a PSA “bounce” after 125I-based prostate brachytherapy

Follow

Get every new post delivered to your Inbox.

Join 269 other followers